Adiponectin Provides Additional Information to Conventional Cardiovascular Risk Factors for Assessing the Risk of Atherosclerosis in Both Genders

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Yoon, Jin Ha ^a,b   Kim, Sung Kyung ^a   Choi, Ho June ^a   Choi, Soo In ^a   Cha, So Youn ^a   Koh, Sang Baek ^a   Kang, Hee Taik ^b,c   Ahn, Song Vogue ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84885156608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075535     Document Type: Article

References (28)

1. Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, et al. (2008) Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 78: 376-384.
2. Ahima RS, (2006) Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14Suppl 5: 242S-249S.
3. Fortuno A, Rodriguez A, Gomez-Ambrosi J, Fruhbeck G, Diez J, (2003) Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem 59: 51-60.
4. Wang JH, Lee CJ, Lee CC, Chen YC, Lee RP, et al. (2010) Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease. Intern Med 49: 739-747.
5. Iglseder B, Mackevics V, Stadlmayer A, Tasch G, Ladurner G, et al. (2005) Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study. Stroke 36: 2577-2582.
6. Shibata R, Murohara T, Ouchi N, (2012) Protective role of adiponectin in cardiovascular disease. Curr Med Chem 19: 5459-5466.
7. Ahn M-S, Koh S-B, Kim J-Y, Yoon JH, Sung JK, et al. (2011) The association between serum adiponectin and carotid intima media thickness in community based cohort in Korea: The ARIRANG study. Molecular & Cellular Toxicology 7: 33-38.
8. Nilsson PM, Engstrom G, Hedblad B, Frystyk J, Persson MM, et al. (2006) Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 26: 2758-2762.
9. Lindberg S, Mogelvang R, Pedersen SH, Bjerre M, Frystyk J, et al. (2013) Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol 111: 1139-1145.
10. Karakas M, Zierer A, Herder C, Baumert J, Meisinger C, et al. (2010) Leptin, adiponectin, their ratio and risk of coronary heart disease: Results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 209: 220-225.
11. Dullaart RP, Kappelle PJ, Dallinga-Thie GM, (2010) Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome. Atherosclerosis 211: 393-396.
12. Yoon JH, Park JK, Oh SS, Lee KH, Kim SK, et al. (2011) The clustering patterns of metabolic risk factors and its association with sub-clinical atherosclerosis in Korean population. Ann Hum Biol 38: 640-646.
13. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K, (2003) Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14: 561-566.
14. Yoon JH, Park JK, Oh SS, Lee KH, Kim SK, et al. (2011) The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: the Korean Genomic Rural Cohort Study. Clin Chim Acta 412: 2199-2205.
15. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, et al. (2000) Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 102: 1503-1510.
16. Pencina MJ, D'Agostino RB Sr, Steyerberg EW, (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11-21.
17. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, et al. (2003) Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88: 3236-3240.
18. Goldstein BJ, Scalia R, (2004) Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89: 2563-2568.
19. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, et al. (2007) Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 117: 1718-1726.
20. Motoshima H, Wu XD, Mahadev K, Goldstein BJ, (2004) Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells with oxidized LDL. Biochemical and Biophysical Research Communications 315: 264-271.
21. Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, et al. (2006) Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55: 1840-1846.
22. Kotani K, Shimohiro H, Sakane N (2008) The relationship between leptin:adiponectin ratio and carotid intima-media thickness in asymptomatic females. Stroke 39: e32-33; author reply e34.
23. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, et al. (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89: 4053-4061.
24. Lakoski SG, Brosnihan B, Herrington DM, (2005) Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial. Am Heart J 150: 907-911.
25. Seftel AD, (2005) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Urol 174: 1045-1046.
26. Hanley AJ, Williams K, Stern MP, Haffner SM, (2002) Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25: 1177-1184.
27. Fielding AH, Bell JF, (1997) A review of methods for the assessment of prediction errors in conservation presence/absence models. Environmental conservation 24: 38-49.
28. Seino Y, Hirose H, Saito I, Itoh H, (2009) High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 58: 355-360.